Carbonic Anhydrase Inhibitor [EPC]

Carbonic Anhydrase Inhibitor [EPC] was reported 20245 times

Drugs of the Carbonic Anhydrase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPOTONY MACULOPATHY 17 0.4146
1 HAIR FOLLICLE TUMOUR BENIGN 41 0.3694
2 EXERTIONAL RHABDOMYOLYSIS 11 0.2973
3 AMAUROSIS FUGAX 231 0.2145
4 CHOROIDAL DETACHMENT 72 0.1297
5 INTRAOCULAR PRESSURE FLUCTUATION 23 0.1168
6 CHOROIDAL EFFUSION 91 0.1133
7 CONGENITAL INTESTINAL MALFORMATION 13 0.1121
8 INTRAOCULAR PRESSURE DECREASED 59 0.1120
9 CONGENITAL CEREBRAL CYST 12 0.1071
10 BURKHOLDERIA TEST POSITIVE 11 0.0887
11 OCULAR SURFACE DISEASE 24 0.0854
12 EYE ALLERGY 125 0.0806
13 CAPILLARITIS 22 0.0797
14 FLAT ANTERIOR CHAMBER OF EYE 14 0.0782
15 TOTAL LUNG CAPACITY ABNORMAL 30 0.0771
16 PULMONARY VASCULITIS 33 0.0613
17 ACUTE MYOPIA 11 0.0604
18 HYPHAEMA 29 0.0556
19 OPEN ANGLE GLAUCOMA 34 0.0554
20 INTRAOCULAR PRESSURE TEST ABNORMAL 39 0.0553
21 SPIROMETRY ABNORMAL 32 0.0535
22 MITE ALLERGY 33 0.0504
23 MYOTONIA 11 0.0495
24 INTRAOCULAR PRESSURE INCREASED 631 0.0493
25 PUNCTATE KERATITIS 43 0.0468
26 CONGENITAL HYPOTHYROIDISM 12 0.0465
27 CORNEAL INFECTION 10 0.0461
28 MACULAR DETACHMENT 11 0.0455
29 PRODUCT DROPPER ISSUE 35 0.0445
30 URINARY TRACT DISORDER 200 0.0444
31 FAMILIAL PERIODIC PARALYSIS 10 0.0439
32 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 32 0.0437
33 ANTERIOR CHAMBER DISORDER 10 0.0435
34 CAVERNOUS SINUS THROMBOSIS 11 0.0433
35 ANGLE CLOSURE GLAUCOMA 108 0.0423
36 HEPATOSPLENIC T-CELL LYMPHOMA 15 0.0404
37 CONJUNCTIVITIS ALLERGIC 59 0.0398
38 COMPLICATIONS OF BONE MARROW TRANSPLANT 14 0.0388
39 MYCOTIC ALLERGY 33 0.0386
40 CORNEAL OEDEMA 85 0.0379
41 JOINT SPACE NARROWING 11 0.0369
42 HYPOTONY OF EYE 15 0.0357
43 DUST ALLERGY 34 0.0347
44 NON-CARDIOGENIC PULMONARY OEDEMA 35 0.0331
45 HAEMORRHAGIC STROKE 257 0.0329
46 EPIDERMAL NECROSIS 32 0.0329
47 SINGLE UMBILICAL ARTERY 12 0.0325
48 OCULAR DISCOMFORT 360 0.0320
49 FLOPPY IRIS SYNDROME 11 0.0299
50 CORNEAL EROSION 16 0.0297
51 IDIOPATHIC INTRACRANIAL HYPERTENSION 66 0.0293
52 ACIDOSIS HYPERCHLORAEMIC 17 0.0286
53 CORNEAL OPACITY 39 0.0286
54 GROWTH OF EYELASHES 22 0.0278
55 DENTAL RESTORATION FAILURE 19 0.0264
56 GLAUCOMA 505 0.0262
57 IRIS ADHESIONS 13 0.0253
58 KERATIC PRECIPITATES 12 0.0253
59 OCULAR HYPERTENSION 49 0.0252
60 CONJUNCTIVAL HYPERAEMIA 80 0.0224
61 OPTIC NERVE INJURY 26 0.0224
62 CRYSTALLURIA 12 0.0221
63 NEURITIS 34 0.0220
64 TREATMENT FAILURE 1812 0.0218
65 CORNEAL DEPOSITS 16 0.0215
66 CORNEAL DISORDER 44 0.0200
67 EYELID MARGIN CRUSTING 55 0.0190
68 FOREIGN BODY SENSATION IN EYES 120 0.0188
69 REACTION TO PRESERVATIVES 15 0.0184
70 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 37 0.0181
71 GENERALISED OEDEMA 224 0.0181
72 CYSTOID MACULAR OEDEMA 34 0.0180
73 SYMPTOM MASKED 13 0.0179
74 CORNEAL EPITHELIUM DEFECT 10 0.0172
75 FOETAL HEART RATE DECELERATION ABNORMALITY 12 0.0170
76 CARDIAC ANEURYSM 16 0.0161
77 INTRACRANIAL PRESSURE INCREASED 89 0.0160
78 HEAD DISCOMFORT 275 0.0155
79 NASAL DISCHARGE DISCOLOURATION 21 0.0152
80 IRIDOCYCLITIS 48 0.0152
81 PAPILLOEDEMA 67 0.0148
82 CLEAR CELL RENAL CELL CARCINOMA 10 0.0144
83 BENIGN INTRACRANIAL HYPERTENSION 18 0.0143
84 EYE PAIN 809 0.0143
85 PHOTOPHOBIA 269 0.0143
86 DRUG CLEARANCE DECREASED 18 0.0138
87 EYE COLOUR CHANGE 14 0.0138
88 CONJUNCTIVAL OEDEMA 14 0.0136
89 CEREBRAL VENOUS SINUS THROMBOSIS 11 0.0130
90 VITREOUS OPACITIES 11 0.0130
91 OCULAR HYPERAEMIA 613 0.0129
92 BLINDNESS 511 0.0125
93 ACUTE CHEST SYNDROME 11 0.0125
94 INTELLECTUAL DISABILITY 19 0.0125
95 HYPERCAPNIA 37 0.0123
96 OPTIC NERVE DISORDER 19 0.0119
97 METABOLIC ALKALOSIS 19 0.0118
98 EYE IRRITATION 676 0.0117
99 OPTIC ATROPHY 19 0.0117
100 NORMOCHROMIC NORMOCYTIC ANAEMIA 35 0.0116
101 FORCED EXPIRATORY VOLUME DECREASED 33 0.0116
102 EYELID IRRITATION 29 0.0115
103 IRITIS 35 0.0115
104 MYOPIA 27 0.0113
105 ULCERATIVE KERATITIS 31 0.0113
106 EYELID DISORDER 26 0.0113
107 SECONDARY ADRENOCORTICAL INSUFFICIENCY 17 0.0113
108 RESPIRATORY SYMPTOM 32 0.0112
109 ALTERED STATE OF CONSCIOUSNESS 243 0.0112
110 KERATITIS 34 0.0112
111 VISUAL FIELD DEFECT 80 0.0111
112 SUPERFICIAL INJURY OF EYE 12 0.0110
113 VITREOUS HAEMORRHAGE 29 0.0105
114 FOREIGN BODY IN EYE 10 0.0104
115 CARBON DIOXIDE DECREASED 12 0.0104
116 DIPLOPIA 270 0.0104
117 EYELID PAIN 21 0.0103
118 PRODUCT DEPOSIT 16 0.0103
119 HAEMATEMESIS 260 0.0102
120 RESPIRATORY ALKALOSIS 16 0.0098
121 ERYTHEMA OF EYELID 53 0.0098
122 EYE DISCHARGE 100 0.0096
123 PRESYNCOPE 230 0.0095
124 BLINDNESS UNILATERAL 133 0.0094
125 DEATH NEONATAL 13 0.0093
126 BLEPHARITIS 37 0.0092
127 UVEITIS 119 0.0088
128 HYPOCHLORAEMIA 10 0.0085
129 RETINAL DEGENERATION 11 0.0085
130 ABNORMAL SENSATION IN EYE 36 0.0084
131 MACULAR OEDEMA 46 0.0082
132 PRODUCT CONTAINER ISSUE 70 0.0082
133 BLOOD CHLORIDE INCREASED 14 0.0081
134 CATHETER SITE PAIN 21 0.0081
135 RETINAL DISORDER 21 0.0081
136 RETINOPATHY 30 0.0080
137 ASCITES 235 0.0080
138 RETINAL ARTERY OCCLUSION 20 0.0079
139 ENTHESOPATHY 12 0.0077
140 CEREBROSPINAL FLUID LEAKAGE 14 0.0076
141 EYE INJURY 23 0.0076
142 PARALYSIS 108 0.0075
143 TOXIC EPIDERMAL NECROLYSIS 114 0.0075
144 PRODUCT CONTAINER SEAL ISSUE 13 0.0075
145 NEUROLOGICAL SYMPTOM 42 0.0073
146 EYE INFLAMMATION 70 0.0073
147 METABOLIC ACIDOSIS 234 0.0073
148 VISUAL ACUITY REDUCED 237 0.0071
149 OPTIC NEUROPATHY 15 0.0071
150 BLOOD PRESSURE DIASTOLIC ABNORMAL 18 0.0071
151 LIQUID PRODUCT PHYSICAL ISSUE 51 0.0070
152 ARTERIOSCLEROSIS CORONARY ARTERY 46 0.0069
153 EYE OEDEMA 17 0.0069
154 MEDICATION RESIDUE PRESENT 33 0.0069
155 RENAL TUBULAR ACIDOSIS 15 0.0069
156 RETINAL OEDEMA 13 0.0068
157 EYE PRURITUS 228 0.0068
158 HAEMATURIA 226 0.0066
159 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
160 TINNITUS 303 0.0066
161 MULTIPLE-DRUG RESISTANCE 20 0.0064
162 PULMONARY ALVEOLAR HAEMORRHAGE 36 0.0064
163 RETINAL DETACHMENT 58 0.0063
164 CARDIO-RESPIRATORY ARREST 261 0.0062
165 EPIGASTRIC DISCOMFORT 24 0.0061
166 LACRIMATION INCREASED 184 0.0061
167 HYDROCEPHALUS 33 0.0061
168 COMA 284 0.0060
169 WOUND HAEMORRHAGE 22 0.0059
170 VITRITIS 11 0.0059
171 VISION BLURRED 809 0.0059
172 ENDOPHTHALMITIS 34 0.0057
173 BLOOD PRESSURE SYSTOLIC ABNORMAL 14 0.0057
174 CATARACT 335 0.0056
175 PRODUCT PHYSICAL CONSISTENCY ISSUE 31 0.0056
176 RESPIRATORY ACIDOSIS 22 0.0056
177 DUODENAL ULCER HAEMORRHAGE 16 0.0056
178 HYPERAESTHESIA 45 0.0055
179 EYE INFECTION 61 0.0054
180 PRODUCT DELIVERY MECHANISM ISSUE 28 0.0052
181 NEPHROGENIC ANAEMIA 24 0.0052
182 EYELIDS PRURITUS 16 0.0051
183 EYE HAEMORRHAGE 68 0.0051
184 HYPERAEMIA 10 0.0051
185 AORTIC ARTERIOSCLEROSIS 13 0.0050
186 PERICARDIAL HAEMORRHAGE 11 0.0050
187 EYE OPERATION 23 0.0050
188 SWELLING OF EYELID 31 0.0049
189 ASTHENOPIA 27 0.0049
190 PHLEBITIS 25 0.0049
191 BLOOD POTASSIUM ABNORMAL 13 0.0049
192 RETINAL VEIN OCCLUSION 14 0.0049
193 MACULOPATHY 17 0.0048
194 HYPERPARATHYROIDISM SECONDARY 12 0.0048
195 ENCEPHALITIS 33 0.0048
196 HAEMORRHAGE URINARY TRACT 12 0.0047
197 CONJUNCTIVAL HAEMORRHAGE 18 0.0047
198 CONJUNCTIVITIS 87 0.0047
199 EYE DISORDER 154 0.0047
200 MENINGITIS ASEPTIC 21 0.0047
201 EYELID OEDEMA 54 0.0046
202 RETINAL HAEMORRHAGE 33 0.0046
203 REBOUND ACID HYPERSECRETION 14 0.0046
204 HYPOKALAEMIA 213 0.0046
205 CONCOMITANT DISEASE AGGRAVATED 28 0.0045
206 BLINDNESS TRANSIENT 33 0.0045
207 DISEASE RECURRENCE 212 0.0045
208 ACIDOSIS 34 0.0044
209 DRY EYE 222 0.0044
210 CHONDROPATHY 12 0.0044
211 BLOOD POTASSIUM DECREASED 132 0.0044
212 EYE SWELLING 161 0.0043
213 OBSTRUCTIVE AIRWAYS DISORDER 48 0.0043
214 ARTERIOSCLEROSIS 40 0.0042
215 VISUAL IMPAIRMENT 522 0.0042
216 MENINGITIS 28 0.0042
217 THERAPY PARTIAL RESPONDER 65 0.0042
218 FULL BLOOD COUNT ABNORMAL 44 0.0042
219 PRODUCT RESIDUE PRESENT 22 0.0041
220 ELECTROLYTE IMBALANCE 47 0.0040
221 CATARACT OPERATION 24 0.0040
222 DEAFNESS NEUROSENSORY 13 0.0039
223 POLYURIA 32 0.0039
224 MACULAR DEGENERATION 46 0.0038
225 HYPERAMMONAEMIA 19 0.0038
226 ERYSIPELAS 19 0.0038
227 HYPOVOLAEMIA 22 0.0038
228 HYPOTONIA 37 0.0037
229 TACHYCARDIA 319 0.0036
230 VITREOUS FLOATERS 35 0.0036
231 PERIORBITAL SWELLING 20 0.0035
232 CARDIAC FAILURE CHRONIC 15 0.0035
233 POOR VENOUS ACCESS 36 0.0035
234 SYNCOPE 347 0.0035
235 VASCULITIS 40 0.0034
236 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 56 0.0033
237 PRODUCT LABEL ISSUE 22 0.0032
238 MIOSIS 26 0.0032
239 LEUKOENCEPHALOPATHY 12 0.0032
240 PRODUCT SUPPLY ISSUE 23 0.0032
241 BRADYCARDIA 169 0.0032
242 PHOTOPSIA 20 0.0032
243 AMMONIA INCREASED 16 0.0031
244 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
245 URINE ABNORMALITY 14 0.0031
246 PARAESTHESIA 484 0.0031
247 PRE-EXISTING CONDITION IMPROVED 19 0.0030
248 ACUTE RESPIRATORY FAILURE 58 0.0030
249 CEREBRAL ATROPHY 12 0.0030
250 OPTIC NEURITIS 27 0.0030
251 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 23 0.0030
252 TASTE DISORDER 60 0.0030
253 APNOEA 23 0.0030
254 DIABETIC RETINOPATHY 10 0.0029
255 SOCIAL AVOIDANT BEHAVIOUR 17 0.0029
256 SOMNOLENCE 582 0.0029
257 SENSITIVITY TO WEATHER CHANGE 15 0.0028
258 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 152 0.0028
259 PANCREATITIS ACUTE 62 0.0028
260 BLOOD PHOSPHORUS DECREASED 10 0.0027
261 PRODUCT COLOUR ISSUE 14 0.0027
262 DRY MOUTH 221 0.0027
263 NASAL DRYNESS 17 0.0027
264 HEART RATE IRREGULAR 61 0.0027
265 STILLBIRTH 13 0.0027
266 HEART RATE DECREASED 94 0.0027
267 PRODUCT LEAKAGE 15 0.0027
268 SCREAMING 17 0.0027
269 CHILLS 312 0.0027
270 DYSGEUSIA 195 0.0026
271 BLOOD PRESSURE INCREASED 400 0.0026
272 ATAXIA 31 0.0026
273 PULMONARY FIBROSIS 50 0.0026
274 NODULE 34 0.0026
275 HYPERVENTILATION 15 0.0026
276 APHTHOUS ULCER 20 0.0026
277 FEELING OF DESPAIR 12 0.0026
278 CARDIOPULMONARY FAILURE 10 0.0026
279 RASH PAPULAR 57 0.0025
280 MUSCULAR WEAKNESS 289 0.0025
281 INFUSION SITE SWELLING 16 0.0025
282 HORDEOLUM 11 0.0025
283 HYPOXIA 89 0.0025
284 HYPERSENSITIVITY 469 0.0025
285 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
286 SEPSIS 281 0.0025
287 INFUSION SITE ERYTHEMA 21 0.0025
288 BRAIN FOG 39 0.0025
289 END STAGE RENAL DISEASE 45 0.0025
290 MIDDLE INSOMNIA 46 0.0025
291 BLOOD MAGNESIUM DECREASED 21 0.0024
292 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
293 PRODUCT PACKAGING ISSUE 23 0.0024
294 HYPERNATRAEMIA 12 0.0024
295 EAR DISORDER 11 0.0024
296 BLEPHAROSPASM 15 0.0024
297 HALLUCINATIONS, MIXED 10 0.0024
298 COVID-19 PNEUMONIA 28 0.0024
299 PERSONALITY CHANGE 22 0.0024
300 LUNG DISORDER 116 0.0024
301 DRY THROAT 24 0.0024
302 CLOSTRIDIUM DIFFICILE COLITIS 25 0.0024
303 TACHYPNOEA 32 0.0024
304 APATHY 34 0.0023
305 ULCER 37 0.0023
306 CARDIAC TAMPONADE 11 0.0023
307 HYPOACUSIS 99 0.0023
308 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
309 BLOOD PRESSURE FLUCTUATION 55 0.0023
310 PRODUCT USE COMPLAINT 36 0.0023
311 EYELID PTOSIS 23 0.0023
312 CONFUSIONAL STATE 365 0.0023
313 HORMONE LEVEL ABNORMAL 11 0.0023
314 PAROSMIA 17 0.0023
315 NEPHROLITHIASIS 103 0.0022
316 SUBDURAL HAEMATOMA 32 0.0022
317 FACIAL PARALYSIS 19 0.0022
318 SICKLE CELL ANAEMIA WITH CRISIS 35 0.0022
319 FALL 732 0.0022
320 TOXIC ENCEPHALOPATHY 11 0.0022
321 MYALGIA 366 0.0022
322 PARAESTHESIA ORAL 31 0.0021
323 FOETAL GROWTH RESTRICTION 13 0.0021
324 THERAPY NON-RESPONDER 96 0.0021
325 PRODUCTIVE COUGH 101 0.0021
326 VENTRICULAR SEPTAL DEFECT 12 0.0021
327 DRUG INTERACTION 332 0.0021
328 HAEMOPTYSIS 58 0.0021
329 PERIPHERAL COLDNESS 28 0.0020
330 BODY TEMPERATURE DECREASED 20 0.0020
331 BREATH SOUNDS ABNORMAL 10 0.0020
332 FLANK PAIN 19 0.0020
333 HYPERVOLAEMIA 10 0.0020
334 MUSCLE RIGIDITY 24 0.0020
335 PRESCRIBED UNDERDOSE 40 0.0020
336 FLUID INTAKE REDUCED 10 0.0020
337 DEAFNESS UNILATERAL 11 0.0020
338 HYPOPHAGIA 51 0.0020
339 PEMPHIGOID 15 0.0020
340 BLOOD PRESSURE DECREASED 132 0.0020
341 HYPOTHYROIDISM 63 0.0020
342 ASTHENIA 738 0.0020
343 EAR PAIN 38 0.0020
344 VITAMIN D DEFICIENCY 19 0.0019
345 DIZZINESS 969 0.0019
346 SLEEP APNOEA SYNDROME 37 0.0019
347 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 93 0.0019
348 PRODUCT ADMINISTRATION ERROR 39 0.0019
349 HYPOKINESIA 28 0.0019
350 FOETAL DEATH 10 0.0019
351 HEAD INJURY 61 0.0019
352 PNEUMONIA ASPIRATION 48 0.0019
353 ENCEPHALOPATHY 47 0.0019
354 MUSCLE TIGHTNESS 31 0.0019
355 WHEEZING 113 0.0019
356 HYPONATRAEMIA 106 0.0019
357 LYMPHOEDEMA 13 0.0019
358 EXTRASYSTOLES 13 0.0019
359 CARDIAC FLUTTER 12 0.0019
360 APHASIA 56 0.0019
361 HAEMOGLOBIN DECREASED 190 0.0018
362 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 96 0.0018
363 ORTHOSTATIC HYPOTENSION 32 0.0018
364 BRADYPHRENIA 12 0.0018
365 CONDITION AGGRAVATED 557 0.0018
366 DECREASED APPETITE 425 0.0018
367 PNEUMOTHORAX 29 0.0018
368 THROAT IRRITATION 82 0.0018
369 ARRHYTHMIA 86 0.0018
370 INGUINAL HERNIA 11 0.0018
371 CONCUSSION 14 0.0018
372 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 128 0.0018
373 DYSPNOEA 1013 0.0018
374 INTENTIONAL UNDERDOSE 13 0.0018
375 MUSCLE TWITCHING 41 0.0018
376 COUGH 496 0.0018
377 SUBARACHNOID HAEMORRHAGE 18 0.0018
378 ABNORMAL LOSS OF WEIGHT 12 0.0018
379 ATELECTASIS 17 0.0018
380 BRONCHOSPASM 25 0.0018
381 CARDIAC VALVE DISEASE 10 0.0017
382 ASTHMA 197 0.0017
383 HYPERKALAEMIA 61 0.0017
384 ABDOMINAL PAIN UPPER 358 0.0017
385 ACUTE KIDNEY INJURY 266 0.0017
386 HYDRONEPHROSIS 13 0.0017
387 THIRST 31 0.0017
388 COGNITIVE DISORDER 81 0.0017
389 TENDERNESS 18 0.0017
390 INSOMNIA 459 0.0017
391 HALLUCINATION, VISUAL 36 0.0017
392 LETHARGY 98 0.0017
393 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
394 RENAL PAIN 18 0.0017
395 SEASONAL ALLERGY 24 0.0017
396 EXPIRED PRODUCT ADMINISTERED 56 0.0017
397 HYPOTHERMIA 17 0.0017
398 DRUG INTOLERANCE 162 0.0017
399 IMPAIRED DRIVING ABILITY 19 0.0017
400 DECREASED ACTIVITY 18 0.0017
401 RESPIRATORY DISTRESS 46 0.0017
402 BLOOD COUNT ABNORMAL 25 0.0016
403 CHRONIC KIDNEY DISEASE 125 0.0016
404 DEAFNESS 43 0.0016
405 RHINORRHOEA 106 0.0016
406 BLOOD ALBUMIN DECREASED 13 0.0016
407 MYDRIASIS 21 0.0016
408 MADAROSIS 19 0.0016
409 RENAL IMPAIRMENT 137 0.0016
410 COLITIS ISCHAEMIC 11 0.0016
411 ATRIAL FLUTTER 13 0.0016
412 HYPOPHOSPHATAEMIA 12 0.0016
413 HOSPICE CARE 16 0.0016
414 DYSPNOEA EXERTIONAL 61 0.0016
415 STEVENS-JOHNSON SYNDROME 36 0.0016
416 ATRIAL FIBRILLATION 157 0.0016
417 MALNUTRITION 18 0.0016
418 EYE MOVEMENT DISORDER 11 0.0016
419 ABDOMINAL PAIN 373 0.0016
420 DRUG RESISTANCE 41 0.0016
421 VERTIGO 97 0.0016
422 HAEMATOMA 41 0.0016
423 MICTURITION URGENCY 18 0.0016
424 RESPIRATORY TRACT INFECTION 41 0.0016
425 SPINAL COMPRESSION FRACTURE 13 0.0016
426 FACIAL PAIN 14 0.0016
427 BALANCE DISORDER 135 0.0016
428 TUBULOINTERSTITIAL NEPHRITIS 29 0.0015
429 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
430 CARDIOMEGALY 19 0.0015
431 FEELING COLD 43 0.0015
432 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
433 IMPAIRED GASTRIC EMPTYING 21 0.0015
434 BLOOD PRESSURE SYSTOLIC INCREASED 30 0.0015
435 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0015
436 PANIC REACTION 11 0.0015
437 BACTERAEMIA 18 0.0015
438 HYPOAESTHESIA 227 0.0015
439 GRAND MAL CONVULSION 14 0.0015
440 OSTEOPENIA 23 0.0015
441 HEADACHE 946 0.0015
442 STATUS EPILEPTICUS 17 0.0015
443 EPILEPSY 46 0.0015
444 MOUTH HAEMORRHAGE 11 0.0015
445 MUSCLE ATROPHY 19 0.0015
446 BODY HEIGHT DECREASED 16 0.0015
447 OXYGEN SATURATION DECREASED 84 0.0015
448 PSYCHIATRIC SYMPTOM 11 0.0015
449 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
450 ABORTION INDUCED 14 0.0015
451 POOR QUALITY SLEEP 32 0.0015
452 MENTAL STATUS CHANGES 41 0.0015
453 SLUGGISHNESS 15 0.0015
454 FUNGAL INFECTION 49 0.0015
455 CARDIOGENIC SHOCK 21 0.0015
456 TENDON RUPTURE 18 0.0015
457 MALAISE 637 0.0015
458 PHARYNGITIS 18 0.0014
459 FATIGUE 1129 0.0014
460 PRODUCT AVAILABILITY ISSUE 33 0.0014
461 DROOLING 10 0.0014
462 DISTURBANCE IN ATTENTION 78 0.0014
463 RASH ERYTHEMATOUS 69 0.0014
464 FIBROMYALGIA 35 0.0014
465 GASTROENTERITIS 21 0.0014
466 BOWEL MOVEMENT IRREGULARITY 11 0.0014
467 ATRIAL SEPTAL DEFECT 12 0.0014
468 DEMENTIA 40 0.0014
469 DEFAECATION URGENCY 10 0.0014
470 SENSATION OF FOREIGN BODY 12 0.0014
471 SCRATCH 15 0.0014
472 RESPIRATORY FAILURE 103 0.0014
473 MELAENA 31 0.0014
474 SINUSITIS 144 0.0014
475 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
476 EPISTAXIS 105 0.0014
477 MEDICATION ERROR 78 0.0014
478 SKIN HYPERPIGMENTATION 12 0.0014
479 ANURIA 12 0.0014
480 GASTROENTERITIS VIRAL 25 0.0014
481 PULMONARY ARTERIAL HYPERTENSION 20 0.0014
482 BLOOD UREA INCREASED 23 0.0014
483 DYSPHONIA 80 0.0014
484 PULMONARY CONGESTION 18 0.0014
485 INITIAL INSOMNIA 14 0.0014
486 EAR DISCOMFORT 14 0.0014
487 FRUSTRATION TOLERANCE DECREASED 11 0.0014
488 PALPITATIONS 159 0.0014
489 THROMBOSIS 109 0.0014
490 HYPOTENSION 271 0.0013
491 AFFECT LABILITY 13 0.0013
492 SINUS BRADYCARDIA 13 0.0013
493 FEELING ABNORMAL 322 0.0013
494 DIZZINESS POSTURAL 13 0.0013
495 ACCIDENT 16 0.0013
496 DISORIENTATION 53 0.0013
497 THROMBOTIC MICROANGIOPATHY 13 0.0013
498 INTENTIONAL DOSE OMISSION 38 0.0013
499 OFF LABEL USE 1166 0.0013
500 MIGRAINE 127 0.0013
501 PRODUCT TASTE ABNORMAL 18 0.0013
502 OROPHARYNGEAL PAIN 123 0.0013
503 ARTHRALGIA 550 0.0013
504 INFUSION SITE PAIN 17 0.0013
505 UNRESPONSIVE TO STIMULI 34 0.0013
506 DIABETES MELLITUS 100 0.0013
507 HAEMATOCRIT DECREASED 26 0.0013
508 INTENTIONAL PRODUCT USE ISSUE 114 0.0013
509 FEAR 35 0.0013
510 SPEECH DISORDER 68 0.0013
511 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
512 PYREXIA 449 0.0013
513 HYPERCALCAEMIA 16 0.0013
514 HAEMOLYSIS 10 0.0013
515 THERAPEUTIC PRODUCT EFFECT DECREASED 58 0.0013
516 PHARYNGITIS STREPTOCOCCAL 14 0.0013
517 EMPHYSEMA 13 0.0013
518 LIMB INJURY 35 0.0013
519 SPLENOMEGALY 15 0.0013
520 BLOOD CREATININE INCREASED 83 0.0013
521 HAEMORRHAGE INTRACRANIAL 19 0.0013
522 DELIRIUM 44 0.0013
523 HYPERGLYCAEMIA 46 0.0013
524 HYPOAESTHESIA ORAL 19 0.0013
525 COAGULOPATHY 21 0.0013
526 MEMORY IMPAIRMENT 173 0.0013
527 ABDOMINAL DISCOMFORT 211 0.0013
528 ANGINA PECTORIS 36 0.0013
529 UPPER LIMB FRACTURE 25 0.0013
530 PSYCHOTIC DISORDER 37 0.0013
531 DEHYDRATION 167 0.0013
532 RENAL FAILURE ACUTE 53 0.0012
533 GAIT DISTURBANCE 239 0.0012
534 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
535 IMMUNOSUPPRESSION 11 0.0012
536 RENAL INJURY 37 0.0012
537 TRANSFUSION 13 0.0012
538 CHROMATURIA 28 0.0012
539 PRODUCT PRESCRIBING ISSUE 27 0.0012
540 RESPIRATORY RATE INCREASED 11 0.0012
541 NOCTURIA 15 0.0012
542 PANIC ATTACK 45 0.0012
543 CIRCULATORY COLLAPSE 21 0.0012
544 BACTERIAL INFECTION 23 0.0012
545 DIARRHOEA 795 0.0012
546 HEART RATE INCREASED 122 0.0012
547 IRRITABILITY 74 0.0012
548 CHOKING 24 0.0012
549 PHARYNGEAL SWELLING 12 0.0012
550 JAUNDICE 33 0.0012
551 GOUT 22 0.0012
552 HYPERSOMNIA 35 0.0012
553 HICCUPS 10 0.0012
554 LOSS OF CONSCIOUSNESS 156 0.0012
555 SWOLLEN TONGUE 38 0.0012
556 LEUKOCYTOSIS 22 0.0012
557 HEREDITARY ANGIOEDEMA 13 0.0012
558 PERICARDIAL EFFUSION 28 0.0012
559 SOPOR 16 0.0012
560 ORAL PAIN 27 0.0012
561 SNEEZING 27 0.0012
562 AMNESIA 78 0.0012
563 SKIN LACERATION 13 0.0012
564 MALIGNANT MELANOMA 16 0.0012
565 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 242 0.0012
566 OESOPHAGITIS 13 0.0012
567 BRAIN OEDEMA 15 0.0012
568 MUSCULOSKELETAL STIFFNESS 104 0.0012
569 CANDIDA INFECTION 20 0.0012
570 SINUS CONGESTION 16 0.0012
571 DRUG INEFFECTIVE 1560 0.0012
572 PLEURAL EFFUSION 72 0.0012
573 INSURANCE ISSUE 18 0.0012
574 HYPERTENSION 249 0.0012
575 POLLAKIURIA 49 0.0012
576 VOMITING 552 0.0012
577 LIVER DISORDER 52 0.0012
578 DYSARTHRIA 44 0.0012
579 SEIZURE 135 0.0012
580 THYROID DISORDER 18 0.0012
581 IRRITABLE BOWEL SYNDROME 25 0.0012
582 ANKLE FRACTURE 18 0.0012
583 AGEUSIA 29 0.0012
584 PULMONARY OEDEMA 52 0.0012
585 BLOOD URINE PRESENT 22 0.0012
586 DELUSION 18 0.0012
587 DYSPEPSIA 114 0.0012
588 PRODUCT USE IN UNAPPROVED INDICATION 287 0.0012
589 PRURITUS 445 0.0012
590 HYPOGLYCAEMIA 56 0.0012
591 ADRENAL INSUFFICIENCY 14 0.0012
592 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
593 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
594 WEIGHT FLUCTUATION 12 0.0011
595 MASS 16 0.0011
596 HALLUCINATION 86 0.0011
597 DERMATITIS CONTACT 13 0.0011
598 HYPERCHOLESTEROLAEMIA 11 0.0011
599 POOR QUALITY PRODUCT ADMINISTERED 12 0.0011
600 NASOPHARYNGITIS 209 0.0011
601 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
602 NERVOUSNESS 59 0.0011
603 BURNING SENSATION 79 0.0011
604 JOINT INJURY 24 0.0011
605 ISCHAEMIC STROKE 20 0.0011
606 FOETAL EXPOSURE DURING PREGNANCY 91 0.0011
607 SLEEP DISORDER 79 0.0011
608 DIVERTICULITIS 31 0.0011
609 RENAL FAILURE 148 0.0011
610 BLOOD SODIUM DECREASED 21 0.0011
611 LIGAMENT SPRAIN 11 0.0011
612 LACTIC ACIDOSIS 36 0.0011
613 NEURALGIA 27 0.0011
614 FRACTURE 21 0.0011
615 NECK PAIN 62 0.0011
616 BLOOD POTASSIUM INCREASED 18 0.0011
617 DYSKINESIA 45 0.0011
618 MUSCULOSKELETAL DISORDER 21 0.0011
619 SEPTIC SHOCK 48 0.0011
620 SALIVARY HYPERSECRETION 11 0.0011
621 ASPIRATION 12 0.0011
622 PHOTOSENSITIVITY REACTION 18 0.0011
623 NASAL CONGESTION 64 0.0011
624 PROSTATIC SPECIFIC ANTIGEN INCREASED 15 0.0011
625 TOOTH FRACTURE 12 0.0011
626 SKIN DISCOLOURATION 50 0.0011
627 WRIST FRACTURE 13 0.0011
628 CARDIAC DISORDER 101 0.0011
629 DEPRESSED MOOD 57 0.0011
630 SWELLING FACE 70 0.0011
631 THROAT TIGHTNESS 29 0.0011
632 SKIN INFECTION 12 0.0011
633 PRODUCT QUALITY ISSUE 145 0.0011
634 FACE OEDEMA 18 0.0011
635 LIMB DISCOMFORT 33 0.0011
636 ANGER 36 0.0011
637 CEREBRAL INFARCTION 26 0.0011
638 MOOD ALTERED 29 0.0011
639 REBOUND EFFECT 12 0.0011
640 FLUID RETENTION 54 0.0011
641 MOVEMENT DISORDER 34 0.0011
642 HEPATOCELLULAR INJURY 15 0.0011
643 FOOT FRACTURE 20 0.0011
644 DYSPHAGIA 100 0.0011
645 SCAB 12 0.0011
646 LIP SWELLING 35 0.0010
647 NAUSEA 830 0.0010
648 CARDIAC FAILURE 84 0.0010
649 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
650 MOUTH ULCERATION 22 0.0010
651 GASTROOESOPHAGEAL REFLUX DISEASE 84 0.0010
652 INCONTINENCE 11 0.0010
653 NIGHTMARE 36 0.0010
654 BRONCHITIS 77 0.0010
655 PHARYNGEAL OEDEMA 16 0.0010
656 DERMATITIS ALLERGIC 13 0.0010
657 DYSURIA 38 0.0010
658 LIVER FUNCTION TEST ABNORMAL 30 0.0010
659 ARTHRITIS 81 0.0010
660 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
661 SPINAL PAIN 12 0.0010
662 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
663 TREATMENT NONCOMPLIANCE 56 0.0010
664 RIB FRACTURE 21 0.0010
665 CARDIAC FAILURE CONGESTIVE 82 0.0010
666 URINARY RETENTION 34 0.0010
667 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
668 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
669 CARDIOMYOPATHY 15 0.0010
670 INFLUENZA 113 0.0010
671 BIPOLAR DISORDER 11 0.0010
672 BACK INJURY 11 0.0010
673 CHEST PAIN 187 0.0010
674 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
675 CYSTITIS 32 0.0010
676 HYPERLIPIDAEMIA 12 0.0010
677 HIATUS HERNIA 13 0.0010
678 BACK PAIN 233 0.0010
679 SHOCK 23 0.0010
680 SPINAL FRACTURE 20 0.0010
681 PAIN IN EXTREMITY 294 0.0010
682 URINARY TRACT INFECTION 170 0.0010
683 PALLOR 27 0.0010
684 NERVE INJURY 11 0.0010
685 DISEASE PROGRESSION 117 0.0010
686 GASTRITIS 26 0.0010
687 MUSCULOSKELETAL DISCOMFORT 17 0.0010
688 MUSCLE SPASMS 181 0.0010
689 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
690 AGGRESSION 49 0.0010
691 PULMONARY EMBOLISM 93 0.0010
692 HAEMORRHOIDS 19 0.0010
693 UPPER RESPIRATORY TRACT INFECTION 45 0.0010
694 MITRAL VALVE INCOMPETENCE 11 0.0010
695 MUSCULOSKELETAL CHEST PAIN 15 0.0010
696 KIDNEY INFECTION 19 0.0010
697 WEIGHT DECREASED 270 0.0010
698 WOUND 27 0.0010
699 PRODUCT PRESCRIBING ERROR 23 0.0010
700 LUNG INFECTION 15 0.0010
701 PRODUCT DOSE OMISSION 63 0.0010
702 DYSSTASIA 28 0.0010
703 CONTRAINDICATED PRODUCT ADMINISTERED 29 0.0010
704 CHEST DISCOMFORT 98 0.0010
705 CYANOSIS 15 0.0010
706 ACUTE MYOCARDIAL INFARCTION 28 0.0009
707 MENTAL IMPAIRMENT 23 0.0009
708 HEMIPARESIS 16 0.0009
709 TRANSAMINASES INCREASED 21 0.0009
710 RESPIRATORY TRACT CONGESTION 15 0.0009
711 SWELLING 88 0.0009
712 TREMOR 156 0.0009
713 EAR INFECTION 25 0.0009
714 RESPIRATORY DISORDER 28 0.0009
715 CRYING 34 0.0009
716 HYPOMAGNESAEMIA 13 0.0009
717 RECTAL HAEMORRHAGE 40 0.0009
718 FREQUENT BOWEL MOVEMENTS 25 0.0009
719 THERAPEUTIC RESPONSE DECREASED 56 0.0009
720 COVID-19 162 0.0009
721 OEDEMA 50 0.0009
722 PAIN IN JAW 26 0.0009
723 JOINT STIFFNESS 24 0.0009
724 DEPRESSION 208 0.0009
725 CONTUSION 88 0.0009
726 BEDRIDDEN 12 0.0009
727 URINARY INCONTINENCE 27 0.0009
728 DERMATITIS 19 0.0009
729 PRODUCT SUBSTITUTION ISSUE 52 0.0009
730 JOINT SWELLING 109 0.0009
731 HIP FRACTURE 29 0.0009
732 RASH MACULO-PAPULAR 20 0.0009
733 PANCYTOPENIA 50 0.0009
734 DRUG-INDUCED LIVER INJURY 28 0.0009
735 CORONARY ARTERY DISEASE 27 0.0009
736 TYPE 2 DIABETES MELLITUS 30 0.0009
737 BLOOD CALCIUM DECREASED 10 0.0009
738 CYST 11 0.0009
739 ANAEMIA 168 0.0009
740 RESTLESS LEGS SYNDROME 16 0.0009
741 DRUG ADMINISTRATION ERROR 27 0.0009
742 ERUCTATION 17 0.0009
743 SCIATICA 14 0.0009
744 ANXIETY 249 0.0009
745 ILLNESS 90 0.0009
746 SENSORY DISTURBANCE 14 0.0009
747 FEMUR FRACTURE 27 0.0009
748 PULMONARY HYPERTENSION 18 0.0009
749 PRODUCT DOSE OMISSION ISSUE 254 0.0009
750 NEUROPATHY PERIPHERAL 82 0.0009
751 AGRANULOCYTOSIS 16 0.0009
752 COORDINATION ABNORMAL 12 0.0009
753 ERECTILE DYSFUNCTION 22 0.0009
754 BLOOD PRESSURE ABNORMAL 17 0.0009
755 HOT FLUSH 64 0.0008
756 DRUG LEVEL INCREASED 14 0.0008
757 EXTRAPYRAMIDAL DISORDER 21 0.0008
758 HYPOCALCAEMIA 16 0.0008
759 BLOOD IRON DECREASED 10 0.0008
760 SEDATION 22 0.0008
761 MUSCULOSKELETAL PAIN 44 0.0008
762 CEREBRAL HAEMORRHAGE 30 0.0008
763 RENAL DISORDER 39 0.0008
764 ORAL CANDIDIASIS 11 0.0008
765 WHITE BLOOD CELL COUNT INCREASED 32 0.0008
766 DIABETIC KETOACIDOSIS 20 0.0008
767 TOXICITY TO VARIOUS AGENTS 140 0.0008
768 PRESCRIBED OVERDOSE 16 0.0008
769 THERAPEUTIC RESPONSE UNEXPECTED 37 0.0008
770 PNEUMONIA 266 0.0008
771 OEDEMA PERIPHERAL 100 0.0008
772 RESTLESSNESS 30 0.0008
773 SCAR 14 0.0008
774 CELLULITIS 41 0.0008
775 LOWER RESPIRATORY TRACT INFECTION 37 0.0008
776 CEREBROVASCULAR ACCIDENT 137 0.0008
777 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
778 SINUS DISORDER 16 0.0008
779 CORONARY ARTERY OCCLUSION 11 0.0008
780 INTENTIONAL PRODUCT MISUSE 70 0.0008
781 C-REACTIVE PROTEIN INCREASED 29 0.0008
782 FULL BLOOD COUNT DECREASED 16 0.0008
783 LIVER FUNCTION TEST INCREASED 17 0.0008
784 PAIN 485 0.0008
785 GASTRIC ULCER 15 0.0008
786 BODY TEMPERATURE INCREASED 16 0.0008
787 GASTROINTESTINAL DISORDER 70 0.0008
788 GAIT INABILITY 26 0.0008
789 HERNIA 15 0.0008
790 SINUS TACHYCARDIA 11 0.0008
791 BLOOD CHOLESTEROL INCREASED 36 0.0008
792 NERVOUS SYSTEM DISORDER 24 0.0008
793 HEPATIC FAILURE 23 0.0008
794 IMMUNE SYSTEM DISORDER 10 0.0008
795 FLATULENCE 43 0.0008
796 GASTRIC DISORDER 26 0.0008
797 PANCREATITIS 40 0.0008
798 PRODUCT USE ISSUE 142 0.0008
799 UNDERDOSE 55 0.0008
800 ASPARTATE AMINOTRANSFERASE INCREASED 40 0.0008
801 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
802 BLISTER 42 0.0007
803 CYTOKINE RELEASE SYNDROME 15 0.0007
804 HAIR TEXTURE ABNORMAL 10 0.0007
805 PRODUCT PHYSICAL ISSUE 15 0.0007
806 DRUG EFFECT INCOMPLETE 27 0.0007
807 NEUROTOXICITY 13 0.0007
808 EOSINOPHILIA 13 0.0007
809 FEEDING DISORDER 15 0.0007
810 INFUSION RELATED REACTION 49 0.0007
811 ANAPHYLACTIC SHOCK 19 0.0007
812 INFLAMMATION 38 0.0007
813 RED BLOOD CELL COUNT DECREASED 21 0.0007
814 SURGERY 43 0.0007
815 LIVER INJURY 18 0.0007
816 LOWER LIMB FRACTURE 14 0.0007
817 STAPHYLOCOCCAL INFECTION 24 0.0007
818 PERIPHERAL SWELLING 112 0.0007
819 ECONOMIC PROBLEM 11 0.0007
820 CONSTIPATION 158 0.0007
821 EXPOSURE DURING PREGNANCY 45 0.0007
822 DRUG DISPENSING ERROR 11 0.0007
823 INFECTION 104 0.0007
824 HUNGER 10 0.0007
825 APHONIA 10 0.0007
826 UNEVALUABLE EVENT 54 0.0007
827 HERPES ZOSTER 41 0.0007
828 ACCIDENTAL OVERDOSE 26 0.0007
829 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
830 FEBRILE NEUTROPENIA 47 0.0007
831 AGITATION 52 0.0007
832 EJECTION FRACTION DECREASED 11 0.0007
833 EATING DISORDER 15 0.0007
834 CARDIAC ARREST 58 0.0007
835 HEPATIC STEATOSIS 13 0.0007
836 THINKING ABNORMAL 13 0.0007
837 SKIN ULCER 18 0.0007
838 ERYTHEMA 143 0.0007
839 PRURITUS GENERALISED 15 0.0007
840 ROAD TRAFFIC ACCIDENT 29 0.0007
841 SKIN LESION 19 0.0007
842 HALLUCINATION, AUDITORY 11 0.0007
843 FAECES DISCOLOURED 15 0.0007
844 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
845 INCREASED APPETITE 13 0.0007
846 POST PROCEDURAL COMPLICATION 13 0.0007
847 DRUG EXPOSURE DURING PREGNANCY 23 0.0007
848 ABDOMINAL PAIN LOWER 17 0.0007
849 DISCOMFORT 41 0.0007
850 HAEMATOCHEZIA 37 0.0007
851 BLOOD GLUCOSE DECREASED 32 0.0007
852 MENTAL DISORDER 29 0.0007
853 VIRAL INFECTION 22 0.0007
854 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118 0.0007
855 PREGNANCY 13 0.0006
856 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
857 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
858 MOBILITY DECREASED 46 0.0006
859 OSTEONECROSIS 21 0.0006
860 HYPERHIDROSIS 82 0.0006
861 ALOPECIA 125 0.0006
862 WEIGHT INCREASED 142 0.0006
863 HOSPITALISATION 97 0.0006
864 DEVICE USE ISSUE 11 0.0006
865 STOMATITIS 38 0.0006
866 DRUG PRESCRIBING ERROR 12 0.0006
867 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
868 HEPATIC FUNCTION ABNORMAL 23 0.0006
869 ORAL HERPES 12 0.0006
870 BONE PAIN 36 0.0006
871 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
872 CONVULSION 35 0.0006
873 THROMBOCYTOPENIA 68 0.0006
874 INFLUENZA LIKE ILLNESS 50 0.0006
875 ABASIA 15 0.0006
876 DISABILITY 12 0.0006
877 OSTEONECROSIS OF JAW 15 0.0006
878 ABNORMAL BEHAVIOUR 24 0.0006
879 RASH 264 0.0006
880 FEELING HOT 37 0.0006
881 ACCIDENTAL EXPOSURE TO PRODUCT 62 0.0006
882 RASH MACULAR 21 0.0006
883 PRODUCT DOSE OMISSION IN ERROR 17 0.0006
884 DEEP VEIN THROMBOSIS 39 0.0006
885 LYMPHADENOPATHY 21 0.0006
886 BONE MARROW FAILURE 12 0.0006
887 OSTEOARTHRITIS 25 0.0006
888 NIGHT SWEATS 19 0.0006
889 NO ADVERSE EVENT 106 0.0006
890 TOOTH DISORDER 13 0.0006
891 ABDOMINAL DISTENSION 61 0.0006
892 OSTEOPOROSIS 24 0.0006
893 GLOSSODYNIA 13 0.0006
894 RASH GENERALISED 15 0.0006
895 PROTEINURIA 11 0.0006
896 INTERSTITIAL LUNG DISEASE 28 0.0006
897 ECZEMA 30 0.0006
898 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
899 RASH PRURITIC 30 0.0006
900 RHABDOMYOLYSIS 23 0.0006
901 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
902 ADVERSE DRUG REACTION 49 0.0005
903 MYOCARDIAL INFARCTION 95 0.0005
904 LABORATORY TEST ABNORMAL 16 0.0005
905 INJURY 38 0.0005
906 SKIN DISORDER 18 0.0005
907 LOCALISED INFECTION 13 0.0005
908 MUCOSAL INFLAMMATION 14 0.0005
909 PERITONITIS 11 0.0005
910 INTESTINAL OBSTRUCTION 20 0.0005
911 COLITIS 20 0.0005
912 THERAPY CESSATION 27 0.0005
913 INCORRECT DOSE ADMINISTERED 120 0.0005
914 PLATELET COUNT DECREASED 56 0.0005
915 FEELING JITTERY 10 0.0005
916 ARTHROPATHY 29 0.0005
917 CHOLELITHIASIS 17 0.0005
918 BLOOD GLUCOSE INCREASED 97 0.0005
919 HEPATITIS 13 0.0005
920 ABNORMAL DREAMS 14 0.0005
921 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
922 HAEMORRHAGE 52 0.0005
923 ANGIOEDEMA 22 0.0005
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
925 ILL-DEFINED DISORDER 30 0.0005
926 ANAPHYLACTIC REACTION 27 0.0005
927 ACNE 37 0.0005
928 URTICARIA 81 0.0005
929 SUICIDAL IDEATION 44 0.0005
930 RESPIRATORY ARREST 13 0.0005
931 MOOD SWINGS 15 0.0005
932 PRODUCT STORAGE ERROR 41 0.0005
933 ADVERSE EVENT 43 0.0005
934 HEPATIC ENZYME INCREASED 31 0.0005
935 MATERNAL EXPOSURE DURING PREGNANCY 40 0.0004
936 BLOOD BILIRUBIN INCREASED 12 0.0004
937 SKIN EXFOLIATION 37 0.0004
938 NEOPLASM MALIGNANT 29 0.0004
939 ABORTION SPONTANEOUS 17 0.0004
940 DEATH 362 0.0004
941 THERAPY INTERRUPTED 30 0.0004
942 NEUTROPENIA 57 0.0004
943 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
944 LUNG NEOPLASM MALIGNANT 17 0.0004
945 BREAST CANCER FEMALE 11 0.0004
946 RHEUMATOID ARTHRITIS 46 0.0004
947 FLUSHING 41 0.0004
948 DRUG DOSE OMISSION 66 0.0004
949 NEOPLASM PROGRESSION 13 0.0004
950 EXTRA DOSE ADMINISTERED 15 0.0004
951 NEUTROPHIL COUNT DECREASED 15 0.0004
952 DEVICE ISSUE 33 0.0004
953 OVERDOSE 79 0.0004
954 EMOTIONAL DISORDER 11 0.0004
955 MULTIPLE SCLEROSIS 17 0.0004
956 INJECTION SITE MASS 13 0.0004
957 LEUKOPENIA 17 0.0003
958 IMPAIRED HEALING 11 0.0003
959 INJECTION SITE HAEMORRHAGE 26 0.0003
960 COMPLETED SUICIDE 27 0.0003
961 DEVICE BREAKAGE 13 0.0003
962 WITHDRAWAL SYNDROME 13 0.0003
963 DRY SKIN 41 0.0003
964 SKIN IRRITATION 14 0.0003
965 INJECTION SITE PAIN 93 0.0003
966 VAGINAL HAEMORRHAGE 13 0.0003
967 PSORIASIS 39 0.0003
968 EMOTIONAL DISTRESS 36 0.0003
969 INJECTION SITE BRUISING 23 0.0003
970 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
971 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
972 DEVICE DISLOCATION 11 0.0003
973 INJECTION SITE ERYTHEMA 31 0.0002
974 COLITIS ULCERATIVE 11 0.0002
975 DRUG EFFECT DECREASED 13 0.0002
976 BREAST CANCER 22 0.0002
977 DEVICE LEAKAGE 10 0.0002
978 PROSTATE CANCER 18 0.0002
979 INJECTION SITE SWELLING 17 0.0002
980 SUICIDE ATTEMPT 13 0.0002
981 SKIN BURNING SENSATION 15 0.0002
982 INTENTIONAL OVERDOSE 13 0.0002
983 DEVICE DIFFICULT TO USE 12 0.0002
984 INJECTION SITE PRURITUS 12 0.0002
985 INJECTION SITE REACTION 11 0.0002
986 DRUG WITHDRAWAL SYNDROME 13 0.0001